Small Interfering RNA (siRNA)

Small Interfering RNA (siRNA)

Small Interfering RNA (siRNA) is a small exogenous double-stranded RNA (dsRNA) (20-25 nucleotides), which triggers the RNA interference (RNAi) pathway. The sense strand is broken down as the short dsRNA unwinds. With various protein components, the antisense strand forms the RNA-induced silencing complex (RISC). The target gene's mRNA is specifically complementary to the antisense strand that RISC retains. The target gene's mRNA can be cut and degraded by the nuclease activity of RISC, which can also stop the target gene from being expressed. Inhibition of mRNA translation is the result of incomplete complementarity.

Small Interfering RNA (siRNA) related products

Structure Cat No. Product Name CAS No. Product Description
V75255 AB-729 sodium 2826248-50-2 AB-729 sodium is an siRNA that can inhibit viral replication and reduces HBV (hepatitis B virus) antigen through RNA interference (RNAi).
V77237 AS-Patisiran AS-Patisiran is the antisense strand of Patisiran.
V75257 ATU027 1415935-22-6 ATU027 is an siRNA that silences PKN3 expression in vascular endothelium.
V78286 ATU027 sodium ATU027 sodium is an siRNA that silences PKN3 expression in vascular endothelium.
V71321 Bamosiran (SYL040012) 1337968-84-9 Bamosiran is an siRNA targeting β-adrenergic receptor 2, used to reduce intraocular pressure
V78343 Bamosiran sodium (SYL040012 sodium) Bamosiran sodium is an siRNA targeting β-adrenergic receptor 2, used to reduce intraocular pressure
V75256 Cimdelirsen (ISIS 766720; IONIS-GHR-LRx) 2131025-82-4 Cimdelirsen is a liver-targeted antisense oligonucleotide that reduces growth hormone receptor (GHr) synthesis, thereby inhibiting the harmful effects of growth hormone (GH) hypersecretion and reducing circulating insulin-like growth factor in patients with acromegaly.
V75254 Cimdelirsen sodium (ISIS 766720 sodium; IONIS-GHR-LRx sodium) 2131025-83-5 Cimdelirsen (sodium) is a liver-targeted antisense oligonucleotide that reduces growth hormone receptor (GHr) synthesis, thereby inhibiting the deleterious effects of growth hormone (GH) hypersecretion and reducing circulating insulin in patients with acromegaly.
V79284 Elebsiran sodium (VIR-2218 sodium) Elebsiran sodium is an siRNA against HBV (hepatitis B virus) and hepatitis D virus (HDV) infection.
V75253 Fazirsiran (ARO-AAT) 2175009-08-0 Fazirsiran (ARO-AAT) is a second-generation RNA interference (RNAi) active molecule.
V73137 Fitusiran (ALN-AT3SC; SAR439774) 1499251-18-1 Fitusiran (ALN-AT3SC) is a small interfering RNA that specifically targets antithrombin (AT) messenger RNA to reduce AT production in the liver.
V51385 GalNAc unconjugated/naked Fitusiran GalNAc unconjugated/naked Fitusiran is a small interfering RNA without conjugated GalNAc that specifically targets antithrombin (AT) messenger RNA to reduce AT production in the liver.
V51386 GalNAc unconjugated/naked Inclisiran GalNAc unconjugated/naked Inclisiran is a double-stranded small interfering RNA (siRNA) molecule without conjugated GalNAc that can inhibit the transcription of PCSK-9.
V75258 Lumasiran sodium 1834612-06-4 Lumasiran sodium is an investigational RNA interference (RNAi) agent that reduces hepatic oxalate production by targeting glycolate oxidase.
V80679 Manusiran sodium Manusiran sodium is a potent inhibitor of TMPRSS6 (transmembrane protease serine 6) synthesis.
V51406 Nedosiran (DCR-PHXC) 2266591-83-5 Nedosiran (DCR-PHXC; Rivfloza) is an RNA intervening agent (RNAi) that compensates for lactate dehydrogenase (LDH).
V81009 Olpasiran sodium (AMG 890 sodium; ARC-LPA sodium) Olpasiran sodium is an siRNA that reduces lipoprotein(a) synthesis in the liver.
V51632 PF-04523655 1420046-64-5 PF-04523655 is an siRNA that regulates the RTP801 gene.
V81095 PF-04523655 sodium PF-04523655 sodium is a siRNA targeting the RTP801 gene.
V51408 Revusiran (ALN-TTRSC) 1438322-82-7 Revusiran (ALN-TTRSC) is a first-generation short interfering RNA targeting transcytosin (TTR) mRNA.
Contact Us Back to top